OLFM4 was closely associated with digestive diseases, whose dysregulation had been detected in gastrointestinal malignancies, including gastric cancer, colorectal cancer, pancreatic cancer, and gallbladder cancer [34]. Here, OLFM4 is linked to colorectal cancer.